Piramal Pharma Limited — Important, 26-05-2025: General Updates

Piramal Pharma Limited demonstrated strong corporate governance with timely board evaluations, audit committee approvals for related party transactions, and transparent disclosures. No regulatory issues or penalties were reported, and statutory auditors remained unchanged, reflecting stable oversight and compliance frameworks. This supports steady operational transparency and governance discipline.